Skip to main content
. 2023 Dec 4;76(6):e20220578. doi: 10.1590/0034-7167-2022-0578

Chart 2. Studies analyzed according to Database/Journal, title, authors, methodological design, year of publication, country of origin of the study, 2022.

Author/Title Year
Country
Design/Sample Objective/ Interventions Outcomes Level of Evidence
Carr, Rippey, Cooke(20)
“Factors associated with peripheral intravenous cannulation first time insertion success in the emergency department”.
2019 Australia Prospective observational
879 patients
(n=1,201 PVC)
To identify the incidence of factors associated with peripheral intravenous infusion and the success rate of first versus two or more punctures. Incidence of first puncture success rate = 645/879. Success related to age and palpability of the patient’s vein, as well as practitioner’s confidence and experience.
3.e
Sweeny et al.(21)
“The experience of patients at high risk of difficult peripheral intravenous cannulation: An Australian prospective observational study”.
2022 Australia Prospective observational
n=1,084
To identify patients with difficult peripheral intravenous cannulation (DPIVC) Patient characteristics (absence of visible or palpable vein, history of difficult PVC) type of PVC (larger caliber), site (hand and wrist) were pointed out as factors.
3.e
Marsh et al.(22)
“Peripheral intravenous catheter non-infectious complications in adults: A systematic review and meta-analysis”.
2020 Australia Systematic review with 103 studies
(n= 96,777 PVC)
To point out main peripheral complications related to PVC use and where they were inserted. Incidence of phlebitis (23.8%) and infiltration (13.7%) being significantly higher when catheters were inserted in the emergency department.
1.b
Mihala et al.(23)
“Phlebitis signs and symptoms with peripheral intravenous catheters”.
2018 Australia Descriptive observational
n=3,283
To calculate incidence of signs and symptoms for diagnosis of phlebitis and their correlations. Considerably low incidence and only correlations observed were heat x stiffness, heat x swelling and heat x erythema. 4.a
Marsh et al.(24)
“Devices and dressings to secure peripheral venous catheters: A Cochrane systematic review and meta-analysis”.
2017 Australia Systematic review with meta-analysis of 6 studies (n=1,539) To evaluate the effects of fixation devices on the incidence of catheter loss. Less PVC detachment with transparent dressing compared to gauze.
1.a
Schmutz et al.(25)
“Dislodgement forces and cost effectiveness of dressings and securement for peripheral intravenous catheters: A randomized controlled trial”.
2020 Germany Randomized controlled trial
n= 209
Force required to remove a PVC versus four dressing and fixation methods. Sterile absorbent dressing covered by two incisive polyester wool elastics had higher strength and better cost-effectiveness compared to the other techniques. 1.c
Rickard et al.(26)
“Dressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE):a pragmatic, randomized controlled, trial”.
2018 Australia Randomized controlled trial
n= 1,807
Effectiveness and costs of three types of standard borderless polyurethane dressing. No significant results were observed. These methods are associated with loss of PVCs and low durability.
1.c
Corley et al.(27)
“Peripheral intravenous catheter securement: An integrative review of contemporary literature around medical adhesive tapes and supplementary securement products”.
2022 Australia Integrative review with 19 studies
n=43,683 PVC
Synthesize the evidence related to medical adhesive tapes for PVCs. The quality assessment identified high risk of bias or confounding factors. The authors concluded that the evidence is limited.

4.b
Keogh et al.(28)
“Implementation and evaluation of short peripheral intravenous catheter flushing guidelines: a stepped wedge cluster randomized trial”.
2020 Australia Randomized controlled trial
n= 619
Evaluated the impact of a multifaceted intervention for PVC maintenance. lushing with 0.9% NaCL administered via an already prepared syringe with ready-to-use system showed a difference in risk (-8%, 95% CI -14 to -1, p = 0.032) compared to the control group with standard care.

1.d
Marsh et al.(29)
“Securement methods for peripheral venous catheters to prevent failure: A randomized controlled pilot trial”.
2015 Australia Randomized controlled trial
n=89
Evaluating the effectiveness of four safety methods to prevent PVC-related failures Catheter failure was lowest in the tissue adhesive group (14%) and highest in the control group (38%).
1.c
Marsh et al.(30)
“How many audits do you really need?: Learnings from 5-years of peripheral intravenous catheter audits”.
2021 Australia Prospective observational
n=2,274 PVC
Determine the optimal number of PVC patients for clinical audits. Authors defined that optimal values should be between 100 and 250 PVC per audit round, depending on the prevalence of complication.
3.e
Dutra et al.(31)
“Prevention of events with vascular catheters: Validation of an instrument”.
2021
Brazil
Methodological study
n=50
To validate an instrument that identifies factors that hinder PVC insertion and maintenance. Instrument proved to be valid (high Content Index) and reliable (through Interobserver reliability using Kappa coefficient). 4.c
Yagnik, Graves, Thong(32).
“Plastic in patient study: Prospective audit of adherence to peripheral intravenous cannula monitoring and documentation guidelines, with the aim of reducing future rates of intravenous cannula-related complications”.
2017 Australia Prospective observational
n=102
To improve compliance of PVC documentation and monitoring through three “The plastic in patient - PIP” interventions. Documentation improved in the post-intervention group (36.4 x 50%, p = 0.025). Early identification for non-indication of PVC and a trend towards a reduction in PVC-related phlebitis also had positive results post-intervention.

3.c
Webster et al.(33)
“Clinically indicated replacement versus routine replacement of peripheral venous catheters”.
2019 Australia Systematic review with meta-analysis of 9 studies
(n = 7,412)
To evaluate the effects of PVC removal when clinically indicated versus routine catheter removal. There is no clear difference in the rates of catheter-related infection, phlebitis and pain in the two groups. There is moderate-certainty evidence that catheter infiltration and blockage are lower when access is changed routinely. With moderate certainty evidence, there was a reduction in device-related costs when clinically indicated.


1.a
Ray-Barruel et al.(34)
“The I-DECIDED clinical decision-making tool for peripheral intravenous catheter assessment and safe removal: a clinimetric evaluation”.
2020 Australia Methodological study
n=68
To validate an 8-step tool for device assessment and decision making. “I-DECIDED” tool demonstrated strong content validity, with high reliability and replicability for advising PVC-related decision making and assistance.
4.c

PVC - Peripheral venous catheter; PVP - Peripheral venous puncture.